The United States Patent and Trademark Office (USPTO) has granted a patent to Hwang Woo-suk for the technology behind the controversial work he and his team did a decade ago—at the time it was announced that the team had ...
Scientists in the city at the center of China's virus outbreak have applied to patent a drug made by U.S. company Gilead Sciences Inc. to treat the disease, possibly fueling conflict over technology policy that helped trigger ...
Feb 6, 2020
0
1
Medical groups mounted a new legal bid Monday to break a US pharma giant's hold on a hepatitis C drug whose price—costing thousands of dollars for a typical course—has unleashed a fierce patent battle.
Mar 27, 2017
0
8
A medical charity scored a small victory Wednesday in its bid to break a US pharma giant's hold on an eye-wateringly expensive Hepatitis C drug when a European body partially revoked the firm's patent.
Oct 5, 2016
0
0
A rapid HIV diagnostic kit for developing nations, designed by Cambridge University researcher Helen Lee, won the Popular Prize at the European Inventor Awards on Thursday.
Jun 9, 2016
0
53
French charity Medecins du Monde (MdM) on Tuesday said it was contesting a European patent awarded to a hepatitis drug made by US firm Gilead Sciences, arguing the treatment was too costly.
Feb 10, 2015
0
7
A US-based patient rights group said Saturday it has sought to block a bid by California-based Gilead Sciences to obtain an Indian patent for a potentially blockbuster drug to treat hepatitis C.
Nov 24, 2013
0
0
European bioethicists raised the red flag Thursday over an American patent for a method that could allow people to choose genetic traits like eye colour in children sired from donor eggs or sperm.
Oct 3, 2013
0
0
India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies that say they ...
Mar 31, 2013
0
0
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive ...
Mar 5, 2013
3
0
